北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 期刊论文
学科主题: 临床医学
题名:
Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients
作者: Tang, Lei1; Zhang, Xiao-Peng1; Sun, Ying-Shi1; Shen, Lin2; Li, Jian2; Qi, Li-Ping1; Cui, Yong1
刊名: RADIOLOGY
发表日期: 2011-03-01
DOI: 10.1148/radiol.10100402
卷: 258, 期:3, 页:729-738
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Radiology, Nuclear Medicine & Medical Imaging
研究领域[WOS]: Radiology, Nuclear Medicine & Medical Imaging
关键词[WOS]: TARGETED THERAPY ; HEPATOCELLULAR-CARCINOMA ; EMISSION-TOMOGRAPHY ; RADIATION-THERAPY ; BREAST-CANCER ; RECTAL-CANCER ; SOLID TUMORS ; FDG-PET ; MRI ; GIST
英文摘要:

Purpose: To prospectively investigate the use of the apparent diffusion coefficient (ADC) as an early response indicator in patients with gastrointestinal stromal tumors (GISTs) treated with imatinib mesylate.

Materials and Methods: This study was approved by the institutional review board and written informed consent was obtained from all patients. Diffusion-weighted magnetic resonance (MR) imaging was performed in 32 patients with GISTs before and 1, 4, and 12 weeks after treatment with a tyrosine kinase inhibitor, imatinib mesylate. The measurable lesions were classified as having responded well or poorly according to size alterations at clinical evaluation following the first round of treatment (3 months). A linear mixed-effects model was applied to analyze changes in the ADCs of tumors during treatment and to compare the variation and slopes of the time-dependent ADC curves between the good-and poor-response groups.

Results: There were 56 lesions in the good-response group and 35 in the poor-response group. An early (1 week after therapy) noticeable and statistically significant (P < .001) increase in the ADC was observed in the good-response group (median ADC increase, 44.8%) but not in the poor-response group (median ADC increase, 1.5%). The time-dependent ADC variation was significantly different between the good- and poor-response groups, with a sharper median ADC increase displayed in the former (week 1: 44.8% vs 1.5%; week 4: 80.4% vs 7.8%; week 12: 89.6% vs 16.7%; F = 25.78, P < .001). The largest difference in the weekly percentage increase in ADC between the good-and poor-response groups was observed at 1 week after therapy (week 0-1: 44.8% vs 1.5%; week 1-4: 7.0% vs 2.8%; week 4-12: 1.6% vs 0.7%). The pretherapy mean ADC (+/- standard deviation) of lesions in the good-response group (1.06 [x 10(-3) mm(2)/sec] +/- 0.27) was signifi cantly lower than that in the poor-response group (1.24 [x 10(-3) mm(2)/sec] +/- 0.32) (F = 8.34, P = .005).

Conclusion: Comparatively low pretherapy ADC and marked ADC increase at 1 week after therapy is associated with good response to imatinib mesylate in patients with GISTs. (C)RSNA, 2010

语种: 英语
所属项目编号: 2011CB707705 ; 30970825 ; 7092020
项目资助者: National Basic Research Program of China (973 Program) ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China
WOS记录号: WOS:000287573100009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51374
Appears in Collections:北京大学临床肿瘤学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Radiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Gastroenterol, Beijing 100142, Peoples R China

Recommended Citation:
Tang, Lei,Zhang, Xiao-Peng,Sun, Ying-Shi,et al. Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients[J]. RADIOLOGY,2011,258(3):729-738.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Tang, Lei]'s Articles
[Zhang, Xiao-Peng]'s Articles
[Sun, Ying-Shi]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Tang, Lei]‘s Articles
[Zhang, Xiao-Peng]‘s Articles
[Sun, Ying-Shi]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace